bioRxivNeurosciencePreprint
Delineation of the pathogenic presynaptic mechanisms of synaptotagmin-1 variants
Holly MellandiD, Kyla Venter, Stephanie L. Leech, Amy Ferreira, Elyas H. ArvelliD, Kate BakeriD, Sarah L. GordoniD
Abstract
Missense variants in the presynaptic calcium sensor synaptotagmin-1 (SYT1) are associated with an autosomal dominant neurodevelopmental disorder (NDD). These cause dominant-negative impairment of evoked neurotransmitter release in a mutation-specific manner; however, whether NDD-associated variants also perturb the auxiliary functions of SYT1 remains unknown. We investigated whether the expression of SYT1 variants in cultured hippocampal neurons altered either action potential-independent spontaneous synaptic vesicle exocytosis or synaptic vesicle endocytosis. SYT1 variants did not induce dominant-negative impairment of either process, confirming that defective evoked exocytosis is the major pathogenic mechanism of SYT1-associated NDD. To examine the differential impacts of human variants on evoked exocytosis, both NDD-associated and strategic mutations were used to explore the functional importance of two distinct Ca2+-binding residues in the C2B domain. We show that both the nature of the amino acid change and the specific residues targeted determine the severity of exocytic disturbance. Together, this work informs understanding of SYT1 function and further clarifies potential mechanistic targets for treating SYT1-associated NDD.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adaptive functions correlate with evoked neurotransmitter release in SYT1-associated neurodevelopmental disorder
Paul Yangho Park, Lauren E. Bleakley, … Sarah L. Gordon·bioRxiv·Nov 25, 2023
- Regulation of spontaneous neurotransmission and homeostatic synaptic plasticity by synaptotagmin-1 disease variants at the SNARE primary interface.
Elena D. Bagatelas, Ok‐Ho Shin, … Ege T. Kavalali·bioRxiv·Feb 18, 2026
- Disease-causing mutations in Synaptotagmin can act via dominant-negative, gain-of-function or haploinsufficient mechanisms
Zhuo Guan, Maria Bykhovskaia, J. Troy Littleton·bioRxiv·Mar 18, 2026
- Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder
Holly Melland, Fabian Bumbak, … Kate Baker·Genetics in MedicinePeer-reviewed·Jan 28, 2022
- Synaptotagmin 1 oligomerization via the juxtamembrane linker regulates spontaneous and evoked neurotransmitter release
Kevin C. Courtney, Jason Vevea, … Edwin R. Chapman·Proceedings of the National Academy of SciencesPeer-reviewed·Nov 22, 2021
- Synaptotagmin 9 modulates spontaneous neurotransmitter release in striatal neurons by regulating substance P secretion
Michael J. Seibert, Chantell S. Evans, … Edwin R. Chapman·Journal of NeurosciencePeer-reviewed·Feb 2, 2023